| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 5 |
| NetGPI | no | yes: 0, no: 5 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 5 |
| GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: E9B5J0
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.593 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.748 |
| DEG_SPOP_SBC_1 | 54 | 58 | PF00917 | 0.290 |
| DOC_MAPK_MEF2A_6 | 8 | 15 | PF00069 | 0.701 |
| DOC_PP2B_LxvP_1 | 2 | 5 | PF13499 | 0.724 |
| DOC_WW_Pin1_4 | 50 | 55 | PF00397 | 0.338 |
| LIG_BRCT_BRCA1_1 | 86 | 90 | PF00533 | 0.581 |
| LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.740 |
| LIG_eIF4E_1 | 7 | 13 | PF01652 | 0.658 |
| LIG_FHA_1 | 55 | 61 | PF00498 | 0.393 |
| LIG_FHA_1 | 81 | 87 | PF00498 | 0.406 |
| LIG_LIR_Apic_2 | 48 | 54 | PF02991 | 0.347 |
| LIG_LIR_Gen_1 | 29 | 37 | PF02991 | 0.231 |
| LIG_LIR_Nem_3 | 29 | 34 | PF02991 | 0.231 |
| LIG_LIR_Nem_3 | 63 | 68 | PF02991 | 0.420 |
| LIG_LIR_Nem_3 | 87 | 91 | PF02991 | 0.593 |
| LIG_PCNA_yPIPBox_3 | 8 | 16 | PF02747 | 0.655 |
| LIG_REV1ctd_RIR_1 | 88 | 94 | PF16727 | 0.615 |
| LIG_SH2_PTP2 | 51 | 54 | PF00017 | 0.347 |
| LIG_SH2_STAP1 | 82 | 86 | PF00017 | 0.470 |
| LIG_SH2_STAT3 | 7 | 10 | PF00017 | 0.660 |
| LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.347 |
| LIG_SH2_STAT5 | 66 | 69 | PF00017 | 0.264 |
| LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.305 |
| LIG_SH3_3 | 65 | 71 | PF00018 | 0.406 |
| MOD_CK1_1 | 53 | 59 | PF00069 | 0.224 |
| MOD_CK1_1 | 80 | 86 | PF00069 | 0.478 |
| MOD_CMANNOS | 85 | 88 | PF00535 | 0.518 |
| MOD_GlcNHglycan | 45 | 48 | PF01048 | 0.473 |
| MOD_GSK3_1 | 50 | 57 | PF00069 | 0.253 |
| MOD_GSK3_1 | 77 | 84 | PF00069 | 0.470 |
| MOD_N-GLC_1 | 54 | 59 | PF02516 | 0.593 |
| MOD_NEK2_1 | 77 | 82 | PF00069 | 0.470 |
| MOD_Plk_4 | 77 | 83 | PF00069 | 0.508 |
| MOD_ProDKin_1 | 50 | 56 | PF00069 | 0.338 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3S7X8J1 | Leishmania donovani | 88% | 100% |
| A4HBB7 | Leishmania braziliensis | 74% | 100% |
| A4IAG6 | Leishmania infantum | 89% | 100% |
| Q4Q2E6 | Leishmania major | 87% | 100% |